PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15213258-0 2004 Simvastatin modulates angiotensin II signaling pathway by preventing Rac1-mediated upregulation of p27. Simvastatin 0-11 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 99-102 15213258-3 2004 The current study explored the modulatory effects of simvastatin (SMV) on the angiotensin II (Ang II)-induced Rac1-mediated, upregulation of cyclin-dependent kinase inhibitor p27. Simvastatin 53-64 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 175-178 15213258-3 2004 The current study explored the modulatory effects of simvastatin (SMV) on the angiotensin II (Ang II)-induced Rac1-mediated, upregulation of cyclin-dependent kinase inhibitor p27. Simvastatin 66-69 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 175-178 15213258-5 2004 Co-treatment of cells with SMV (1 microM) inhibited Ang II-induced upregulation of p27 protein. Simvastatin 27-30 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 83-86 15213258-6 2004 Addition of mevalonate (200 microM) or geranylgeranyl pyrophosphate (5 microM) reversed the inhibitory effect of SMV on p27 protein expression, suggesting that the effect of SMV is geranylgeranyl dependent. Simvastatin 113-116 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 120-123 15213258-6 2004 Addition of mevalonate (200 microM) or geranylgeranyl pyrophosphate (5 microM) reversed the inhibitory effect of SMV on p27 protein expression, suggesting that the effect of SMV is geranylgeranyl dependent. Simvastatin 174-177 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 120-123 15213258-8 2004 It was also shown that SMV, by inhibiting Rac1 activity, reversed Ang II-induced increase in intracellular H2O2 production, Akt activation, and p27 protein expression. Simvastatin 23-26 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 144-147 12963647-7 2003 Longitudinal transcriptional profiling revealed that simvastatin downregulated the inflammatory genes fos, jun, and tumor necrosis factor-alpha and upregulated the cell cycle inhibitor p27Kip1, endothelial nitric oxide synthase, and bone morphogenetic protein receptor type 1a. Simvastatin 53-64 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 185-192 12379583-8 2002 In rats with pressure overload, SIM treatment significantly reduced Ras membrane targeting, Ras in vivo activation, ERK2 phosphorylation, and the ratio cdk4/p27(kip1). Simvastatin 32-35 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 157-160 12379583-8 2002 In rats with pressure overload, SIM treatment significantly reduced Ras membrane targeting, Ras in vivo activation, ERK2 phosphorylation, and the ratio cdk4/p27(kip1). Simvastatin 32-35 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 161-165 10412745-6 1999 The aim of the present study is to examine the effect of simvastatin, one of the HMG-CoA reductase inhibitors, on the glomerular cell proliferation and on the expression of CDK2 or p27Kip1 in mesangial cells in experimental glomerulonephritis in vivo. Simvastatin 57-68 cyclin-dependent kinase inhibitor 1B Rattus norvegicus 181-188